Stock KLY KALYTERA THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Kalytera Therapeutics Inc Toronto S.E.

Equities

KLY

CA48349P1036

End-of-day quote Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- PTS -.--% Intraday chart for Kalytera Therapeutics Inc -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI
c7d8f44d655e399d2eaed07a1.2GdU1W-ObmMxJ_jR6GHHGvcM3k2_LGPxq5H2QpsDH2A.oBICvAL7Wzxhbo6fjTaGTr5VtD6SThO-7PXDdflNaSWsETWnXM8vMlVwlw~83beb0a367ba893c8e19f283411c61d2
  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. KLY Stock
  5. Charts Kalytera Therapeutics Inc
  6. News Chart